Restricted accessResearch articleFirst published online 2010-01
Up-regulation of the Apo/Fas (CD95) complex on neutrophils harvested during cardiac surgery: distinct findings in patients operated on with or without the use of cardiopulmonary bypass
Aims: In a group of patients undergoing cardiac surgery performed both with (“on-pump”) and without the use (“offpump”) of cardiopulmonary bypass (CPB), we studied the changes of neutrophil membrane apoptosis-inducing complex Apo/Fas.
Methods: Expression of Apo/Fas (CD95) on leukocytes was evaluated by flow cytometry.
Results: In “on-pump” patients, we found an increase in the expression of CD95 median intensity fluorescence (MFI) on granulocytes from a baseline level median=56, (Q 1=45.5, Q3=64) to a median=88, (Q1=62, Q 3=109.5; p<0.01) at the 3rd postoperative day and median=74, (Q1=63, Q3=84.5; p<0.01) at the 7th postoperative day. In “off-pump” patients, granulocyte CD95 MFI was median=55, (Q1=51, Q3=84) before surgery. The significant increase was found on the 3rd postoperative day only; median=90, (Q 1=66; Q3=98; p<0.05). A similar pattern in the CD95 expression was also found if percentage changes of granulocyte CD95 MFI were followed. Moreover, the significantly increased Apo/Fas expression expressed as a percentage change of CD95 MFI was found in “on-pump” patients compared to “off-pump” patients, both at the 3rd postoperative day (p<0.05) and at the 7th postoperative day (p<0.01).
Conclusions: This is the first direct evidence of increasing densities of the Apo/Fas complex on neutrophils in cardiac surgical patients.
Levy JH, Tanaka KAInflammatory response to cardiopulmonary bypass. Ann Thorac Surg2003; 75: S725-S720.
2.
Giannoudis PVCurrent concepts of the inflammatory response after major trauma: an update. Injury2003 ; 34: 397-404.
3.
Anselmi A., Abbate A., Girola F., et al. Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardio-Thorac Surg2004; 25: 304-311.
4.
Droemann D., Aries SP, Hansen F., et al. Decreased apoptosis and increased activation of alveolar neutrophils in bacterial pneumonia. Chest2000; 117: 1679-1684.
5.
Lozano FS, Cascajo C., García-Sánchez E. , et al. Bacterial translocation as a source of Dacron-graft contamination in experimental aortic operation: the importance of controlling SIRS. Surgery2006; 140: 83-92.
6.
Blomquist S. , Gustafsson V., Manolopoulos T., et al. Clinical experience with a novel endotoxin adsorbtion device in patients undergoing cardiac surgery . Perfusion2009; 24(1): 13-17.
7.
Nathoe HM, Moons KGM, van Dijk D., et al. Risk and determinants of myocardial injury during off-pump coronary artery bypass grafting. Am J Cardiol2006; 97: 1482-1486.
8.
Wan IY, Arifi AA, Wan S., et al. Beating heart revascularization with or without cardiopulmonary bypass: evaluation of inflammatory response in a prospective randomized study . J Thorac Cardiovasc Surg2004; 127: 1624-1631.
9.
Franke A., Lante W., Fackeldey V., et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know?Eur J CardioThorac Surg2005; 28: 569-575.
10.
Hoel TN, Videm V., Mollnes TE, et al. Off-pump cardiac surgery abolishes complement activation. Perfusion2007; 22(4): 251-256.
11.
Franke A., Lante W., Fackeldey V., et al. Proinflammatory and antiinflammatory cytokines after cardiac operation: different cellular sources at different times. Ann Thorac Surg2002; 74: 363-370.
12.
Savill J.Apoptosis in resolution of inflammation. J Leukocyte Biol1997; 61: 375-380.
13.
Kunes P., Lonsky V., Mandak J., et al. The long pentraxin PTX3 in cardiac surgery: distinct responses in "on-pump" and "off-pump" patients. Scand Cardiovasc J2007; 41: 171-179.
14.
Serhan CN, Savill J.Resolution of inflammation: the beginning programs the end. Nat Immunol2005; 6: 1191-1197.
15.
Johnson GB, Brunn GJ, Platt JLAn endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol2004; 172: 20-24.
Moller CH, Penninga L., Wetterslev J., et al. Clinical outcomes in randomized trials of off- vs. on-pump coronary artery bypass surgery: systematic review with meta-analyses and trial sequential analyses. Eur Heart J2008; 29: 2601-2616.
18.
Racz MJ, Hannan EL, Isom OW, et al. A comparison of short- and long-term outcomes after off-pump and on-pump coronary artery bypass graft surgery with sternotomy. J Am Coll Cardiol2004; 43: 557-564.
19.
Sistino JJUsing decision-analysis and meta-analysis to predict coronary artery bypass surgical outcomes - a model for comparing off-pump surgery to miniaturized cardiopulmonary bypass circuits. Perfusion2008; 23(5): 255-260.
20.
Kofidis T., Baraki H., Singh H., et al. The minimized extracorporeal circulation system causes less inflammation and organ damage. Perfusion2008 ; 23(3): 147-151.
21.
Bical OM, Fromes Y., Gaillard D., et al. Comparison of the inflammatory response between miniaturized and standard CPB circuits in aortic valve surgery. Eur J CardioThorac Surg2006; 29: 699-702.
22.
Zarbock A., Ley K.Mechanisms and consequences of neutrophil interaction with the endothelium . Am J Pathol2008; 172: 1-7.
23.
Garlichs CD , Eskafi S., Cicha I., et al. Delay of neutrophil apoptosis in acute coronary syndromes. J Leukoc Biol2004; 75: 828-835.
24.
Krammer PHCD95 (APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol1999; 71: 163-210.
Cassatella MAOn the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils. J Leukocyte Biol2006; 79: 1140-1149.
27.
Lum JJ, Bren G., McClure R., et al. Elimination of senescent neutrophils by TNF-related apoptosis-inducing ligand. J Immunol2005; 175: 1232-1238.
28.
Chello M., Mastroroberto P., Quirino A., et al. Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary bypass. Ann Thorac Surg2002; 73: 123-130.
29.
Chello M., Anselmi A., Spadaccio C., et al. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg2007; 83: 1374-1380.
30.
Scholz M., Simon A., Berg M., et al. In vivo inhibition of neutrophil activity by a FAS (CD95) stimulating module: arterial in-line application in a porcine cardiac surgery model. J Thorac Cardiovasc Surg2004; 127: 1735-1742.
